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Acne is a chronic inﬂammatory disease of the pilosebaceous follicle. One of the main pathogenetic factors in acne
is the increased proliferation of Propionibacterium acnes (P. acnes) in the pilosebaceous unit. We investigated
whether direct interaction of P. acnes with keratinocytes might be involved in the inﬂammation and ductal hype-
rcorniﬁcation in acne. The capacities of different P. acnes strains to activate the innate immune response and the
growth of cultured keratinocytes were investigated. We have found that two clinical isolates of P. acnes signif-
icantly induced human b-defensin-2 (hBD2) messenger RNA (mRNA) expression; in contrast a third clinical isolate
and the reference strain (ATCC11828) had no effect on hBD2 mRNA expression. In contrast, all four strains sig-
nificantly induced the interleukin-8 (IL-8) mRNA expression. The P. acnes-induced increase in hBD2 and IL-8 gene
expression could be inhibited by anti-Toll-like receptor 2 (TLR2) and anti-TLR4 neutralizing antibodies, suggesting
that P. acnes-induced secretion of soluble factors in keratinocytes are both TLR2 and TLR4 dependent. In addition,
the clinical isolate P. acnes (889) was capable of inducing keratinocyte cell growth in vitro. Our ﬁndings suggest
that P. acnes modulates the antimicrobial peptide and chemokine expression of keratinocytes and thereby con-
tributes to the recruitment of inﬂammatory cells to the sites of infections.
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Skin is the first barrier that invading microbes have to pass
when entering the organism. The key cellular components
of the pathophysiologic processes of the skin are the ker-
atinocytes, cells that are in a unique position between the
interface of the environment and the host organism.
Through the secretion of soluble factors such as cytokines
and antimicrobial peptides, keratinocytes are able to main-
tain the immune response of the skin. This regulation of the
defense mechanisms is the key feature in the protection of
the host as normal human skin is colonized with a wide
variety of microorganisms such as Propionibacterium acnes
(P. acnes), Staphylococcus epidermidis, and Malessezia
furfur. In addition to normal flora, the skin is constantly
challenged by pathogens, most of which do not cause
clinical disease.
P. acnes is a Gram-positive anaerobe bacteria found in
normal human cutaneous flora and is thought to play a
major role in acne, a chronic inflammatory disease of the
pilosebaceous unit (Koreck et al, 2003). It is proposed that
hypercornification of the outer root sheath and the pilose-
baceous duct, increased sebum production, abnormalities
of the normal microbial flora, and inflammation are the major
factors of the pathogenesis of acne (Toyoda and Morohashi,
2001). Although several lines of evidence suggest the direct
role of P. acnes in acne (Leyden et al, 1998), little is known
about the mechanism by which P. acnes contributes to the
pathogenesis of acne. Kim et al (2002) have shown that in
acne lesions, Toll-like receptor (TLR)2-expressing macroph-
ages are surrounding the pilosebaceous follicles and that P.
acnes induced cytokine production of monocytes via TLR2.
The importance of P. acnes is further suggested by the ob-
servation that the presence of antibiotic-resistant strains
of P. acnes may be associated with therapeutic failure
(Zouboulis and Piquero-Martin, 2003; Oprica et al, 2004).
Additionally, after complete sequencing of the P. acnes
genome, Bruggemann et al (2004) identified surface-asso-
ciated and immunogenic factors that might be involved in
acne formation. As P. acnes is a resident of human cuta-
neous flora and more than 80% of the human population
denotes acne in some stage of life; we hypothesized that
the contribution of P. acnes in acne pathogenesis is isolate
specific.
The human skin expresses a number of proteins that play
a part in host defense. Antimicrobial peptides of the b-de-
fensin family are small, cationic proteins produced in re-
sponse to microbial infections and are expressed in all
human epithelial tissues tested so far. To date, three human
b-defensins (hBD) are shown to play a role in the defense of
Abbreviations: hBD2, human b-defensin-2; IL-8, interleukin-8; P.
acnes, Propionibacterium acnes; PBS, phosphate-buffered saline;
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the skin, namely human b-defensin-1, -2, and -3 (hBD1,
hBD2, and hBD3). These defensins are expressed either
constitutively or upregulated in response to microbial or
pro-inflammatory stimuli (Raj and Dentino, 2002). Besides
destroying various microorganisms, hBD2 contributes to
the regulation of host-adaptive immunity as it is chemotac-
tic for immature dendritic cells, induces the migration of
CD45RO memory T cells (Yang et al, 1999), and also acts as
a chemoattractant for neutrophils through CCR6 (Ni-
yonsaba et al, 2004). Its murine homologue, mBD2, is an
endogenous ligand of TLR4 (Biragyn et al, 2002).
TLRs play a crucial role in the induction of antimicrobial
responses in different cells (O’Neill, 2004; Takeda and Akira,
2004). Seven of 11 human TLRs, TLR1–6, and TLR9 are
known to have an important role in sensing microbial ligand-
derived infections in keratinocytes (Mempel et al, 2003;
Pivarcsi et al, 2003, 2004). In our previous study (Pivarcsi
et al, 2003), we have shown that TLR2 and TLR4 expressed
on keratinocytes are primarily responsible for sensing pepti-
doglycan (PGN) and lipopolysaccharide (LPS), respectively.
As diverse defense responses may influence the clin-
ical course of infection, characterization of the host’s anti-
microbial peptide and cytokine production in response to
P. acnes could lead to a better understanding of acne and
development of more specific therapies. In this study, we
analyzed the messenger RNA (mRNA) and protein expres-
sion of hBD2 and interleukin (IL)-8 in human keratinocytes
exposed to different strains of P. acnes. The roles of TLR2
and TLR4 in sensing P. acnes as well as the effects of P.
acnes strains on the viability of cultured keratinocytes were
examined.
Results
Selective upregulation of hBD2 mRNA in response to P.
acnes treatment in cultured keratinocytes To analyze the
effect of different strains of P. acnes on hBD2 mRNA levels
by quantitative RT-PCR (QRT-PCR), keratinocytes were
treated with or without the bacterial strains for 3 and 24 h.
The hBD2 proved to be differentially inducible in a time-
dependent manner when keratinocytes were treated with
different strains of P. acnes (Fig 1a). Three hours after the
treatment with two clinically isolated strains (889 and 2005),
the increase in hBD2 mRNA level was 5-fold higher com-
pared with 0 h (po0.025), whereas the other two strains
(6609 and ATCC11828) did not modify hBD2 expression
significantly. Twenty-four hours after the treatment, the
hBD2 mRNA levels were back to the control level (Fig 1a).
hBD2 protein expression in cultured keratinocytes in
response to P. acnes (889) treatment Based on QRT-PCR
results, the clinically isolated P. acnes strain 889 was used
in immunostaining experiments for the detection of hBD2
protein expression by keratinocytes in response to P. acnes
treatment. The expression of hBD2 protein was not detect-
able at the beginning of the stimulation (0 h) and it was first
detectable 6 h after the treatment with P. acnes (889) (data
not shown). The treatment for prolonged time (12 and 24 h)
elevated the number of cells that expressed hBD2 protein
(Fig 2); however, not all of the cells expressed hBD2 protein.
Untreated keratinocytes used as controls did not show re-
activity with the anti-hBD2 serum.
The effect of P. acnes treatment on cytokine production
of cultured keratinocytes Changes in IL-8 and IL-1a
mRNA levels were analyzed by QRT-PCR. All four strains
Figure1
The induction of different genes in keratinocytes by Propionibac-
terium acnes is strain-specific. Temporal analysis of gene expression
of human b-defensin-2 (a), interleukin (IL)-8 (b), IL-1a (c), and involucrin
(d) in cultured keratinocytes infected with four different strains of P.
acnes using quantitative RT-PCR. The levels of mRNA were normalized
to the 18S ribosomal RNA (rRNA) level, and are presented as fold in-
creases over the 0 h values.
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significantly (po0.002) increased IL-8 gene expression 3 h
after the treatment (Fig 1b). At 24 and 16 h post-treatment,
the increase in IL-8 gene expression in response to clinical
isolate 6609 and reference strain ATCC11828 was still 3-
fold (po0.002), respectively (Fig 1b). Expression of IL-8
gene was not changed significantly by treatment with clin-
ical isolates 889 and 2005 for 24 h (Fig 1b).
No change in the IL-1a gene expression could be de-
tected (Fig 1c).
Next, we investigated the effect of P. acnes on the IL-8
protein secretion of keratinocytes. As the QRT-PCR results
for the expression of hBD2 mRNA revealed two patterns of
keratinocyte response to P. acnes treatment, we show the
effect of two strains of P. acnes (clinical isolate 889 that
elevated hBD2 expression and reference strain ATCC11828
that did not change hBD2 mRNA expression) on the IL-8
protein secretion of cultured keratinocytes. Cells were treat-
ed with the two selected P. acnes strains and samples were
taken at the same time points post-treatment as for the IL-8
mRNA expression analysis. The amount of secreted IL-8
protein in the cell culture supernatants was measured by
ELISA. We found that both strains significantly (po0.023)
increased the IL-8 protein secretion of keratinocytes at both
time points (Fig 3).
Selective upregulation of involucrin mRNA in response
to P. acnes treatment in cultured keratinocytes To de-
termine the effect of distinct strains of P. acnes on involucrin
gene expression, keratinocytes were treated with or without
the bacterial strains for 3 and 24 h and the mRNA level of
involucrin was determined by QRT-PCR. Involucrin proved
to be differentially inducible in a time-dependent manner
when keratinocytes were treated with different strains of P.
acnes (Fig 1d). No effect was detected 3 h after the treat-
ment; however, 24 h post-treatment, two clinically isolated
strains (889 and 2005) significantly (po0.002) increased the
involucrin mRNA levels (Fig 1d). The other two strains (6609
and ATCC11828) did not modify involucrin gene expression
at all (Fig 1d).
P. acnes (889)-induced upregulation of hBD2 and IL-8
mRNA expression is both TLR2 and TLR4 dependent in
cultured keratinocytes We tested whether TLR2 or TLR4
is involved in the recognition of P. acnes (889) by keratin-
ocytes. Similar to other Gram-positive bacteria, the major
cell-wall component of P. acnes is PGN. The treatment with
P. acnes (889) resulted in the upregulation of hBD2 and IL-8
mRNA expression in keratinocytes 3 h after the stimulation
(Fig 1a and 1b). But, when cultured keratinocytes were pre-
incubated either with anti-TLR2 monoclonal antibody (mAb)
(10 mg per mL) or anti-TLR4 mAb (10 mg per mL) for 1 h
before P. acnes (889) treatment, the upregulation of both
hBD2 and IL-8 mRNA expression was abrogated (Fig 4). We
have previously shown that keratinocytes recognize PGN
Figure 2
The expression of human b-defensin-2 (hBD2) protein in cultured
keratinocytes is upregulated in response to Propionibacterium
acnes (889) treatment as determined by indirect immunofluores-
cence staining. Keratinocytes were treated with P. acnes clinical iso-
late 889 and incubated with rabbit anti-hBD2 antibody; hBD2 staining
was visualized with fluorescein isothiocyanate. Untreated keratinocytes
lack the expression of hBD2 protein (a and c). Stimulation with P. acnes
clinical isolate 889 induced the expression of the hBD2 protein 12 h
post-treatment (b) and an intense staining was observed 24 h post-
treatment (d), suggesting a high level of hBD2 expression. Magnifica-
tions  40.
Figure3
Propionibacterium acnes induces the secretion of interleukin (IL)-8
protein in keratinocytes. Cultured keratinocytes were treated with two
strains of P. acnes (clinical isolate 889 and reference strain ATCC11828)
and the amount of IL-8 in the supernatant medium was measured by
Quantikine human IL-8 ELISA.
Figure4
Blocking of Toll-like receptor (TLR)2 and TLR4 inhibits the Pro-
pionibacterium acnes (889)-induced expression of human b-defen-
sin-2 (hBD2) and interleukin (IL)-8 in keratinocytes as determined
with quantitative RT-PCR. Cultured keratinocytes were grown on six-
well plates and pre-treated with anti-TLR2 (gray bars), anti-TLR4 (white
bars), or isotype-matched control mouse immunoglobulin G (IgG) an-
tibodies (black bars) for 1 h and then stimulated with P. acnes clinical
isolate 889 for 3 h. The expression values are expressed relative to the
values measured in the mIgG-treated controls. 18S ribosomal RNA was
used as internal control.
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through TLR2 (Pivarcsi et al, 2003); therefore, we used PGN
as an internal control (data not shown).
We next investigated the effect of TLR2 and TLR4 block-
ing prior to P. acnes (889) treatment, and the levels of se-
creted IL-8 protein were determined 3 h post-treatment. As
shown in Fig S1, the blocking of TLR2 significantly
(po0.004) suppressed the IL-8 protein secretion of kera-
tinocytes, whereas blocking of TLR4 had no effect on IL-8
protein secretion.
Different effects of P. acnes strains on the viability of
cultured keratinocytes The effect of two previously se-
lected P. acnes strains (clinical isolate 889 and reference
strain ATCC11828) on the viability of cultured keratinocytes
was examined by 3-(4,5-dimethyl thiazol-2-yl) 2,5-diphenyl
tetrazolium bromide (MTT) assays. Neither of the P. acnes
strains had any effect on the viability of keratinocytes 3 h
post-treatment (Fig 5). In addition, the reference strain had
no effect at any other time points (Fig 5). Still the clinical
isolate significantly (po0.001) increased the number of vi-
able cells compared with both control and P. acnes refer-
ence strain-treated keratinocytes 24 h post-treatment, and
this effect was still detectable 48 h post-treatment (Fig 5).
Bactericidal activity of hBD2 on P. acnes strains As the
expression of hBD2 is upregulated in response to some P.
acnes strains we aimed to investigate the bactericidal ac-
tivity of the protein against all four strains of the bacterium
included in our study. Recombinant hBD2, in concentrations
up to 2.5 mg per mL, had no effect on the viability of any of
the tested four P. acnes strains (data not shown). These
data are in good agreement with previous findings where
hBD2 was active against Gram-negative bacteria (e.g., Es-
cherichia coli and Pseudomonas aeruginosa) but it demon-
strated only low, if any, microbicidal activity against Gram-
positive bacteria (e.g. Staphylococcus aureus) (Harder et al,
1997; Schroder, 1999).
Random ampliﬁcation of polymorphic DNA (RAPD) mo-
lecular typing of P. acnes strains As the treatment with
the distinct strains of P. acnes gave different results, we
have determined whether this is because of the variable
genotypic characteristics of the strains. As shown in Fig S2,
the RAPD profile is different for the four P. acnes strains,
containing four to nine bands in the 100–1200 bp range. The
RAPD profiles of the clinical isolates 889, 2005, and 6609
are comparable with the profile of a serotype I biotype
3 strain ATCC6919 (Johnson and Cummins, 1972; Perry
et al, 2003). Moreover, the genotypic profiles of the clinical
isolates 889 and 2005 are very similar to each other, both
lacking the 350 bp band. The clinical isolate 6609 and
the reference strain have six and nine bands, respectively.
It is important to note that both of these strains contain the
350 bp band.
Discussion
P. acnes secretes various biologically active molecules like
enzymes and chemotactic factors, which play a role in the
initiation and perpetuation of the local inflammatory re-
sponse (Vowls et al, 1995). Recently, Mouser et al (2003)
have reported that P. acnes antigens triggers increased
proliferative response in a subpopulation of T helper 1 cells
generated from early inflamed acne lesions. Our results
suggest that in addition to mononuclear cells, keratinocytes
also recognize and respond to P. acnes.
Antimicrobial peptides produced in the skin play an
important role in the elimination of the invading micro-
organisms (Gallo and Huttner, 1998; Bardan et al, 2004). b-
defensins are antimicrobial peptides that protect the epi-
thelia from microbial infection and colonization. hBD2 is one
of the most important host defense molecules denoted by
its inducibility with various pro-inflammatory agents such as
tumor necrosis factor-a (TNF-a), LPS, bacteria, and yeast
(Ali et al, 2001). This inducibility of hBD2 seems to be the
key feature in the immune response of the host. Although
our knowledge about the direct role of hBD2 in the innate
immune response is still fragmentary, it is proposed that
hBD2 has a dual role. Its direct effect is nonoxidative killing
of primarily Gram-negative invading microorganisms (Sch-
roder, 1999), but it also has an immune modulatory effect,
recruiting macrophages and dendritic cells to the place of
infection (Yang et al, 1999). Chronell et al (2001) found that
hBD2 expression is upregulated in acne lesions. They sug-
gested that this upregulation is most probably a secondary
response to the marked perilesional infiltrate and that in-
flammatory cytokines may be responsible for this (Chronell
et al, 2001). Our results demonstrate that keratinocytes
might also be an important source of hBD2 in acne. In ad-
dition, we show that the inducibility of hBD2 in cultured
keratinocytes by P. acnes is isolate specific. Still, only two
of the tested four P. acnes strains upregulated the hBD2
mRNA expression of keratinocytes. There are two reason-
able explanations. First, bacterial-derived proteins, such as
lipoglycans of the Gram-positive cell envelope or the heat
shock proteins are known TLR ligands. To date, several P.
acnes cell envelope components such as GroEL and DnaK
(Farrar et al, 2000) or lipoglycans (Whale et al, 2004) have
been identified. Moreover, Graham et al (2004) have showed
that P. acnes GroEL is able to upregulate the pro-inflam-
matory cytokine production of keratinocytes. Although there
is no direct evidence for the interaction between the TLR
receptors expressed by the keratinocytes and the P. acnes-
Figure 5
Selective effect of Propionibacterium acnes strains on the viability
of keratinocytes. Cultured keratinocytes were treated with two strains
of P. acnes (clinical isolate 889 and reference strain ATCC11828) for
different times. The viability of cells was determined by 3-(4,5-dimethyl
thiazol-2-yl) 2,5-diphenyl tetrazolium bromide assay.
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derived GroEL, DnaK, or lipoglycans one can expect that
these components may act as ligands for the TLR receptors
(Pivarcsi et al, 2005). Underhill and Ozinsky (2002) proposed
a model in which host cells use multiple TLRs for the de-
tection of numerous features on a microbe simultaneously.
According to this model, keratinocytes recognize a number
of P. acnes antigens and effective hBD2 secretion occurs
only if several antigens are concurrently identified and all of
the involved receptors are functional. Second, acne is a
highly heritable disease with supposed genetic factors re-
maining to be determined (Bataille et al, 2002). Hollox et al
(2003) showed that hBD2 gene (DEFB4) is polymorphic in
copy number and there is a significant correlation between
genomic copy number of DEFB4 and levels of its mRNA
transcript in different individuals. It is conceivable that the
hBD2 mRNA level in individuals with low DEFB4 copy
number remains below detectable in response to P. acnes
treatment. hBD2 transcripts were significantly induced as
early as 3 h after treatment with P. acnes clinical isolates
889 and 2005 and cultured keratinocytes already expressed
hBD2 protein 6 h post-treatment. Still, not all of the kera-
tinocytes express hBD2 protein in response to P. acnes
treatment. These data are in good agreement with the find-
ings of Liu et al (2002), who showed that the expression of
hBD2 peptide by human keratinocytes requires differentia-
tion of the cells by growth and maturation as well as cyto-
kine or bacterial stimulus. Moreover, Jeremy et al (2003)
showed that the proliferative activity and the differentiation
status of keratinocytes in the follicular epithelium of the pi-
losebaceous units are comparable with controls and are
significantly lower than in early inflamed lesions. As deter-
mined by MTT assay, P. acnes clinical isolate 889 is able to
stimulate the growth of keratinocytes. In addition, the same
isolate induce differentiation of keratinocytes as demon-
strated by increased expression of involucrin. In contrast,
other stains have no effect on cell growth and differentia-
tion. These data might explain the presence or absence
of acne lesions in different individuals, depending on the
P. acnes strain(s) that is/are present in the follicles.
We also present data that hBD2 does not have any bacte-
riostatic or bactericidal effect against any of the four P. ac-
nes strains included in our experiments. Our results
together with the findings that hBD2 acts as a chemotac-
tic agent for immature dendritic cells, memory T cells, and
neutrophils (Yang et al, 1999; Niyonsaba et al, 2004) lead to
the conclusion that the primary contribution of hBD2 to ac-
ne pathogenesis is the regulation of adaptive immunity by
recruitment of T cells and neutrophils to the place of P.
acnes infection.
Keratinocyte-derived soluble factors are fundamental in
mobilizing leukocytes and neutrophils to the place of skin
infection. Graham et al (2004) showed that P. acnes is able
to stimulate keratinocytes to produce various pro-inflam-
matory cytokines. But only viable stationary-phase bacteria
induced the secretion of IL-1a, whereas both exponential-
and stationary-phase viable bacteria induced TNF-a and
granulocyte/macrophage colony-stimulating factor secre-
tion. None of the four exponential-phase P. acnes strains
included in our experiments induced the expression of IL-
1a. We provide evidence that cultured keratinocytes pro-
duce IL-8 in a time-dependent manner in response to P.
acnes treatment. As IL-8 has mitogenic activity on keratin-
ocytes and is a potent chemoattractant for neutrophils
(Baggiolini and Loetscher, 2000), the major cell type in fully
developed inflammatory lesions (Layton et al, 1998), we
hypothesize that P. acnes-induced IL-8 secretion could also
have a key role in the initiation of inflammatory events in
acne. Moreover, the ductal hyperproliferation of the kera-
tinocytes in acne could also be associated with elevated
levels of IL-8 protein as it promotes proliferation of keratin-
ocytes through their IL-8 receptor (Michel et al, 1992). We
therefore suggest that the primary inflammatory event in
acne pathogenesis is the hBD2 and IL-8 secretion accom-
panied by neutrophil infiltration and ductal hyperprolifera-
tion of keratinocytes.
The release of hBD2 and/or IL-8 is the response of ker-
atinocytes to P. acnes exposure. The first step in the hosts
defense against microbial infection, however, is the detec-
tion of pathogen(s). Kim et al (2002) have shown that P.
acnes induces cytokine release of monocytes via TLR2. We
investigated the molecular mechanism by which P. acnes
elevated the hBD2 and IL-8 mRNA levels in keratinocytes
and present evidence that P. acnes-induced upregulation in
gene expression is both TLR2 and TLR4 dependent. We
have previously shown that the induction of IL-8 gene ex-
pression of keratinocytes in response to treatment with My-
cobacterium tuberculosis also depends on both TLR2 and
TLR4 (Pivarcsi et al, 2003). Additionally, the induction of
myeloid dendritic cells by Mycobacterium bovis bacillus
Calmette-Gue´rin PGN can also be suppressed by simulta-
neous blocking of TLR2 and TLR4 (Uehori et al, 2003). Still
only blocking of TLR2 prior to P. acnes treatment sup-
pressed the IL-8 protein secretion of keratinocytes. As ker-
atinocytes store IL-8 in vesicles, it is reasonable that only de
novo synthesis is inhibited by blocking of TLR4 and the
secretion of intracellularly stored IL-8 occurs independent
of TLR4 signal transduction. According to the model of Un-
derhill and Ozinsky (2002), we propose that some strains of
P. acnes and also species of Mycobacterium have distinct
ligands recognized by TLR2 and/or TLR4 and that both
receptors are involved in the efficient response of kera-
tinocytes to P. acnes and Mycobacterium infection, respec-
tively. As the hBD2 and IL-8 induction is partially inhibited by
TLR2 and TLR4 neutralizing antibodies, however, it is im-
portant to note that other TLRs such as TLR1 or TLR6 and in
addition numerous signal transduction pathways might also
play a role in sensing the bacteria. It is important to
note that the TLR2-dependent bacterial sensing does not
occur via PGN recognition (Travassos et al, 2004). Our
results further suggest that the recognition of microbial
pathogens is cell-type specific and also that distinct strains
of bacteria exhibit different components that are potent TLR
agonists. Recently, Bruggemann et al (2004) have identified
numerous surface-associated and other immunogenic
factors of P. acnes. Using the optimized RAPD method for
typing P. acnes strains (Perry et al, 2003), we demonstrated
that the strains included in our assays display a discrete
RAPD profile. Still the clinical isolates 889 and 2005, strains
that upregulate hBD2 and involucrin gene expression, dis-
play very similar profiles. Sequencing of the amplified prod-
ucts and further characterization of the clinical isolates of P.
acnes may lead to the identification of specific immuno-
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genic factors that might be involved in triggering acne
inflammation.
This report first demonstrates that distinct strains of P.
acnes upregulate hBD2 and IL-8 mRNA and protein ex-
pression in cultured keratinocytes. Here we show that dis-
tinct, genotypically different strains of P. acnes upregulate
hBD2 and IL-8 mRNA and protein expression in keratin-
ocytes via TLR2 and TLR4. In addition, the P. acnes clinical
isolate 889 elevates the growth potential and differentiation
of keratinocytes. This activity of P. acnes may be particu-
larly important in the acute infection of the skin in which
hBD2 participates in bacterial clearance and/or as a
chemoattractant. The results also stress the importance of
keratinocytes as possible sensors of abnormal P. acnes
colonization. In conclusion, our results suggest that kera-
tinocytes secrete hBD2 and IL-8 in response to P. acnes
and that these molecules are potent chemotactic factors for
leukocyte and neutrophil infiltration as well as for keratin-
ocyte growth potential and differentiation at the place of P.
acnes infections.
Materials and Methods
Culture and stimulation of cells Human epidermal keratinocytes
were isolated and cultured as described previously (Pivarcsi et al,
2003). For detailed description, see supporting online information.
The tissue culture dishes and pipettes were free of endotoxin
contamination, according to the manufacturers.
Clinical strains of P. acnes (n¼ 3; 889, 2005, and 6609) were
obtained from the Department of Microbiology, University of
Szeged. Routine phenotyping identification was carried out with
the ATB ID 32A kit (BioMe´rieux, S.A., Marcy l’Etoile, France). P. ac-
nes ATCC11828 was included as a commercially availably reference
strain. The level of endotoxin contamination of P. acnes was quan-
tified according to the European Pharmacopoeia IV and was found
to be o2.6 IU per mL (o5 ng per mL). It has already been dem-
onstrated that the concentration of LPS must be more than 100 ng
per mL for the signaling via TLR4 expressed on keratinocytes (Piv-
arcsi et al, 2003). As the level of endotoxin contamination of P. acnes
strains is at least 20-fold lower, this amount is not sufficient for
signaling via TLR4. P. acnes strains were cultured on prereduced
Columbia agar base (Oxoid, Basingstoke, UK) supplemented with
5% cattle blood, vitamin K1, and hemin, incubated at 371C under
anaerobic conditions (anaerobic chamber; Bactron Sheldon Man,
Cornelius, Oregon) for 48 h. Cells were then centrifuged at 2600 g
for 15 min and the supernatant was discarded. After three washes in
phosphate-buffered saline–ethylene diamine tetraacetic acid (PBS–
EDTA), 15 min each, the cells were harvested in 5 mL PBS–EDTA
and the cell number was calculated by measuring the optical density
of the solution with a Cecil CE 2040 spectrophotometer (Cecil In-
struments, Cambridge, UK) at 600 nm. After an additional centrif-
ugation, the cells were harvested in a complete keratinocyte
medium lacking antibiotic/antimicotic solution and stored at
801C. The freezing had no effect on the viability of the bacteria,
as 100% of the cells were viable after thawing (data not shown).
As P. acnes is very sensitive to different antimicrobial agents,
the CKM was replaced with medium lacking antibiotic/antimicotic
solution 24 h before stimulation of the cultured keratinocytes. P.
acnes strains were thawed and keratinocytes were treated with
bacteria (P. acnes:keratinocyte ratio 50:1). Keratinocytes and bac-
teria were co-cultured at 371C in an atmosphere of 5% (vol/vol)
CO2 in air for 3 and 24 h for mRNA expression: 3, 6, 12, and 24 h
for protein expression; and 3, 24, and 48 h for viability analysis
before harvesting. For negative controls, keratinocytes were cul-
tured with CKM without antibiotics. Following incubation, the
supernatants were collected and the cells were harvested for
mRNA or protein expression analysis.
For blocking experiments, cultured keratinocytes were grown
on six-well plates and pre-treated with functional grade neutralizing
anti-human TLR2 mAb TLR2.1 (10 mg per mL) (eBioscience, San
Diego, California), anti-human TLR4 mAb HTA125 (10 mg per mL)
(eBioscience), or isotype-matched control-purified mouse IgG2a
antibodies (10 mg per mL) (Sigma, St. Louis, Missouri) for 1 h and
then stimulated with P. acnes (889). After 3 h, keratinocytes were
harvested for QRT-PCR analysis and supernatants were collected
for ELISA.
QRT-PCR Total RNA was isolated with Trizol reagent (GibcoBRL,
Eggstein, Germany) according to the manufacturer’s instructions.
RNA concentration was determined by the A260 value of the sam-
ple. Complementary DNA (cDNA) was generated from 1 mg total
RNA using the iScriptTM cDNA Synthesis Kit (Bio-Rad, Hercules,
California) in a final volume of 20 mL. After reverse transcription,
amplification was carried out using iTaq DNA polymerase (Bio-
Rad). QRT-PCR was used to quantify the relative abundance of
each mRNA (iCycler IQ Real Time PCR; BioRad). For the specific
primers used in the experiments see supporting online information
(Table S1).
The amplification protocol contained one cycle of initial dena-
turation at 941C for 5 min followed by varying number of cycles of
denaturation at 941C for 1 min, annealing at 551C for 1 min, ex-
tension at 721C for 2 min, and one cycle of terminal extension at
721C for 10 min. Each primer set gave a unique product. As con-
trols, we used the reaction mixtures without the cDNA.
Immunoﬂuorescent staining The expression of hBD2 was de-
termined by indirect immunohistochemistry. All the steps were
carried out at room temperature (201C). Cell suspensions of
1  105 cells in 50 mL PBS were loaded up in each cuvette of the
cytospin (Wescor, Claremont, Ontario, Canada, Cytopro7620). The
cells were spun at 600 rpm for 6 min and then fixed in freshly
prepared 4% paraformaldehyde in PBS for 30 min. The samples
were then permeabilized with PBS containing 1% Triton-X (Sigma)
for 30 min and blocked in PBS containing 1% bovine serum al-
bumin (BSA) for 20 min. Samples were incubated with 1:500 di-
lution of polyclonal rabbit anti-hBD2 (a kind gift from Dr T. Ganz,
UCLA, USA) in PBS containing 1% BSA and 0.1% Triton-X for 1 h
and washed three times with PBS for 5 min each. The cells were
then incubated with 1:100 dilution of fluorescein isothiocyanate-
labeled goat anti-rabbit immunoglobulin (Sigma) in PBS containing
1% BSA and 0.1% Triton-X for 45 min. After three washes with
PBS, 5 min each, the samples were mounted in mounting medium
(100 mM TRIS pH 8.5; 25% glycerol) and analyzed using epiflu-
orescent illumination of the Axioplan microscope (Opton, Carl
Zeiss AG, Oberkochen, Germany). Images were recorded with an
RT KE camera and SPOT RT v4.0 software (Diagnostic Instru-
ments, Livingstone, Scotland). In all cases, negative controls con-
sisted of preincubation with PBS or substitution of the primary
antibody with pre-immune serum.
ELISA Human IL-8 protein was measured from the supernatants
of third passage epidermal keratinocytes using the Quantikine hu-
man IL-8 immunoassay kit (R&D Systems, Minneapolis, Minnesota)
following the manufacturer’s instructions. We used serial dilutions
of recombinant human IL-8 for standard curves. The optical
density of the wells was determined using a microplate reader
(Multiscan v3.0, Labsystems, Vantaa, Finland) set to 450 nm with a
wavelength correction set to 540 nm.
MTT assay Keratinocytes were seeded in each well of the 96-well
plate at a density of 5  103 cells per well. The treatment of ker-
atinocytes was performed using the P. acnes clinical isolate 889
and the reference strain ATCC11828. Medium alone was used as
control. Three, 24, and 48 h post-treatment, the supernatant was
replaced with RPMI without phenol red and 50 mg of MTT (Sigma)
was introduced into each well and incubated for 4 h at 371C. Living
cells degrade MTT by the mitochondrial succinate dehydrogenase
resulting in MTT formazan. The converted dye was solubilized with
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acidic isopropanol (0.04 M HCl in absolute isopropanol). The op-
tical density of the wells was determined using a microplate reader
(Multiscan v3.0, Labsystems) at 540 nm.
Antibacterial assay Assays measuring the antibacterial activity of
hBD2 against all four strains of P. acnes included in our study were
modified from the methods of Valore et al (1998) and Porter et al
(1997). For detailed description, see supporting online information.
RAPD molecular typing of P. acnes strains RAPD analysis of
the studied P. acnes strains was performed according to the
method of Perry et al (2003). For detailed description, see sup-
porting online information.
Data presentation PCR results were expressed as fold increases
over the 0 h or control values.
For the evaluation of the viability assay, the average absorbance
of the control wells was regarded as 100% and the percentage of
cell growth in each well was calculated (% of control). Each plate
was evaluated at one time point; at least 15 wells comprised one
group. All the data were presented as mean  standard deviation
for at least three experiments. Data were compared using one-way
ANOVA followed by Dunnett’s post hoc test to determine statistical
differences after multiple comparisons (SPSS, SPSS, Chicago, Il-
linois). A probability value of less than 0.05 was considered
significant.
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